Health Technology Assessment of A New Generation of Domestic Cryosurgical System
CAO Xiao-Meng1, GAO Song2, ZHU Xu2, WANG Mei2, ZHANG Hong-Zhi2, CHENG Xue-Hui1*【Abstract】Objective We aimed to evaluate the technology of the new generation of domestic co-ablation system and provid...
China - Morocco Cooperation and Exchange in Ablation Techniques of Minimally Invasive Tumor Treatment
Representatives of Ministry of Health and Social Protection of Morocco were present at Hygea Medical on October 24, 2024 to make a deep and significant exchange meeting for cooperation in ablation tec...
Research of Cryotherapy
(1. School of Medicine Tsinghua University, Beijing 100084, China; 2. Department of Dermatology, the First Affiliated Hospital of Dalian Medical University, Dalian 116011, China)CLC No.: R616.3Documen...
New China-Pakistan cooperation progression, Punjab Province Pakistan signing a memorandum of understanding on cooperation with Hygea Medical
Maryam Nawaz Sharif, Chief Minister of Punjab Province which has the largest population and strongest economy in Pakistan, was present at Hygea Medical for business survey on December 9, 2024, with mo...
Sitemap
Short-Term Efficacy and Safety of Ct-Guided Percutaneous Compound Cryoablation for Liver Malignancies
GUAN Haitao1, LI Tiantian2, FAN Zeyang1, WANG Jian1, ZOU Yinghua1*(1. Department of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing 100034, China; 2. Departmen...
Co-Ablation System’s first commercial use in Turkey has been successfully completed!
On March 8, local time, Professor Yilmaz, a renowned expert from Turkey, successfully performed co-ablation procedures for two cancer patients at Varisson Interventional Radiology Clinics. The postope...
The Clinical and Experimental Study of Ablation Therapy Combined with Chemotherapy or Chemotherapy Alone in the Treatment of Stage IV Pancreatic Cancer
QIAN Zhuyin1*, YU Jianhe2, CHENG Zhi3, CHEN Yiqiu4, ZHU Yichao41Pancreas Center, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210003;2Department of Medical Oncology, Xinghua C...
Great news! BETTER AND BETTER | After NMPA approval, HYGEA's microwave ablation system for minimally invasive tumor treatment now also FDA-approved!
On January 31, 2024, EXCEED™ microwave treatment system and EXACT™ series of microwave ablation probe of Hygea (Beijing) Medical Technology Co., Ltd. successfully obtained permission from the U.S. F...
Privacy Policy
This website collects information from our users at several different points on our website in order to process reservations and better serve you with pertinent information. This website is the sole o...
The Clinical Study of Intraoperative Cryoablation Therapy and Intraoperative Combined Cryoablation and Hyperthermia in the Treatment of Unresectable Pancreatic Cancer
QIAN Zhuyin1*, ZHANG Bin1, CHEN Yiqiu2, WU Yingchun3, GU Yuqing1, ZHU Yichao21Pancreas Center, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 210003; 2Department of Physiology, ...
Cryoablation plus sintilimab and Lenvatinib in advanced or metastatic intrahepatic cholangiocarcinoma: a phase 2 trial
Sijia Gu1,2,3,6, Qiyu Luo1,2,3,6, Yalei Zhang1,4, Ling Qian1,4, Kun Chen1,4, Fei Liang 5,Yudi Hu1,2,3, Runye Zhou1,2,3, Yating Wang1,2,3, Jingjing Liu1,2,3, Zhouyu Ning4,Litao Xu4, Zhiqiang Meng4, Ye ...
Ablation Plus Continuous Anti–PD-1/PD-L1 Therapy in Advanced NSCLC With Oligo-Residual Disease: The BOOSTER Randomized Phase II Trial
Shuo Yang, et al[Abstract]Treatment strategies for advanced non–small cell lung cancer (NSCLC) patients who develop oligo-residual disease (ORD) after responding to immunotherapy remain undefined. Th...
EN 
